Companies File for IPOs costing around $2.6 Billion

Companies File for IPOs costing around $2.6 Billion

Despite the Covid-19 pandemic slowing down primary market activity from its first-quarter boom, Indian companies are still lining up for initial public offerings (IPOs). According to data from primary market tracker Prime Database, companies have...

RBI announces new series of measures with an intent to help businesses beat second wave blues

RBI announces new series of measures with an intent to help businesses beat second wave blues

The central bank Governor Shakti anta Das Wednesday announced a series of measures - from additional loans for enhancing healthcare capacity to dedicated MSME relief packages - to help vulnerable businesses ride out the impact of localized...

RBI Directs Banks No Punitive Action to be taken due to Delay of KYC Updation

RBI Directs Banks No Punitive Action to be taken due to Delay of KYC Updation

The Reserve Bank of India (RBI) instructed banks on Wednesday that no punitive action should be taken in the case of Know Your Customer (KYC) updation delays until December 31, 2021. The RBI move on KYC follows a spurt in complaints from...

Cabinet gives in principle approval for strategic disinvestment of IDBI

Cabinet gives in principle approval for strategic disinvestment of IDBI

The Cabinet Committee on Economic Affairs (CCEA) has announced on Wednesday it has given its in principle approval for strategic disinvestment and transfer of management control in the Industrial Development Bank of India (IDBI). The CCEA,...

Banks Plan to Seek Moratorium and Request Relief from RBI as Second Wave Peaks

Banks Plan to Seek Moratorium and Request Relief from RBI as Second Wave Peaks

The RBI as well as the banks are in the process of evaluating the precise impact of the second wave to resolve the extent of the moratorium that may be essential over the following few months. As the situation of the...

India launched a production scheme which provide the US companies for investment in pharmaceutical, medical devices sector

India launched a production scheme which provide the US companies for investment in pharmaceutical, medical devices sector

India has launched a production scheme which will provide the US companies a new opportunity for investing in pharmaceutical and medical sector. India has reached out to top American pharma companies seeking investment in the...

Wealth Management Platform Nivesh raises 1.6 million USD from Indian Angel Network Fund & Others

Wealth Management Platform Nivesh raises 1.6 million USD from Indian Angel Network Fund & Others

Nivesh, which is a wealth management platform, has raised $1.6 million in a funding round led by the Indian Angel Network (IAN) Fund. Other IAN angel investors, including LV Angel Fund, also participated in the round. The Indian Angel Network...

Goldman Sachs lowers India growth forecast to 11.1% for FY21

Goldman Sachs lowers India growth forecast to 11.1% for FY21

Wall Street brokerage firm Goldman Sachs has lowered its estimate for India’s economic growth to 11.1 per cent in fiscal year to March 31, 2022, as a number of cities and states announced lockdowns of varying intensities to check spread of...

Accenture pledges 25 million US dollars for pandemic relief efforts in India

Accenture pledges 25 million US dollars for pandemic relief efforts in India

Global IT and professional services company Accenture on Tuesday said it has pledged USD 25 million (about Rs 185 crore) for the pandemic relief efforts in India. This is in addition to the company’s ongoing investments in people and...

Local Lockdowns to Cost Indian economy up to $38 billion till June says Barclays

Local Lockdowns to Cost Indian economy up to $38 billion till June says Barclays

Holding liable on the slow pace of vaccinations and uncertainty around the number of those infected and dead in the second wave of COVID-19, global brokerage firm Barclays cut India's FY22 GDP growth estimate to 10% from earlier 11%. If...

Current Issue






🍪 Do you like Cookies?

We use cookies to ensure you get the best experience on our website. Read more...